These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 3783460)
41. Absolute and relative bioavailability of oral acetaminophen preparations. Ameer B; Divoll M; Abernethy DR; Greenblatt DJ; Shargel L J Pharm Sci; 1983 Aug; 72(8):955-8. PubMed ID: 6688635 [TBL] [Abstract][Full Text] [Related]
42. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers. Shah J; Wesnes KA; Kovelesky RA; Henney HR Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304 [TBL] [Abstract][Full Text] [Related]
43. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers. Bittner B; Riek M; Holmes B; Grange S Antivir Ther; 2005; 10(7):803-10. PubMed ID: 16312177 [TBL] [Abstract][Full Text] [Related]
44. A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers. Pan L; Belloni P; Ding HT; Wang J; Rubino CM; Putnam WS Adv Ther; 2017 Sep; 34(9):2071-2082. PubMed ID: 28808905 [TBL] [Abstract][Full Text] [Related]
45. Digoxin bioavailability: formulations and rates of infusions. Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346 [TBL] [Abstract][Full Text] [Related]
46. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [TBL] [Abstract][Full Text] [Related]
47. Absolute bioavailability of amiodarone in normal subjects. Pourbaix S; Berger Y; Desager JP; Pacco M; Harvengt C Clin Pharmacol Ther; 1985 Feb; 37(2):118-23. PubMed ID: 3967454 [TBL] [Abstract][Full Text] [Related]
49. Comparative bioavailability of silibinin in healthy male volunteers. Kim YC; Kim EJ; Lee ED; Kim JH; Jang SW; Kim YG; Kwon JW; Kim WB; Lee MG Int J Clin Pharmacol Ther; 2003 Dec; 41(12):593-6. PubMed ID: 14692709 [TBL] [Abstract][Full Text] [Related]
50. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers. Wright CW; Aikman MS; Werts E; Seabolt J; Haeusler JM Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014 [TBL] [Abstract][Full Text] [Related]
51. Pharmacodynamics, pharmacokinetics, safety, and tolerability of encenicline, a selective α7 nicotinic receptor partial agonist, in single ascending-dose and bioavailability studies. Barbier AJ; Hilhorst M; Van Vliet A; Snyder P; Palfreyman MG; Gawryl M; Dgetluck N; Massaro M; Tiessen R; Timmerman W; Hilt DC Clin Ther; 2015 Feb; 37(2):311-24. PubMed ID: 25438724 [TBL] [Abstract][Full Text] [Related]
52. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study. Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995 [TBL] [Abstract][Full Text] [Related]
53. Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: the V-HeFT paradox. Tam SW; Sabolinski ML; Worcel M; Packer M; Cohn JN Clin Pharmacokinet; 2007; 46(10):885-95. PubMed ID: 17854237 [TBL] [Abstract][Full Text] [Related]
54. Greater bioavailability of digoxin solution in capsules. Studies in the postprandial state. Lindenbaum J Clin Pharmacol Ther; 1977 Mar; 21(3):278-82. PubMed ID: 576419 [TBL] [Abstract][Full Text] [Related]
55. Comparative bioavailability study of cefixime administered as tablets or aqueous solution. Montay G; Masala F; Le Roux Y; Le Liboux A; Uhlrich J; Chassard D; Thebault JJ; Roche G; Frydman A Drugs; 1991; 42 Suppl 4():6-9. PubMed ID: 1725153 [TBL] [Abstract][Full Text] [Related]
56. Comparison of the Pharmacokinetics of the Phase II and Phase III Capsule Formulations of Selumetinib and the Effects of Food on Exposure: Results From Two Randomized Crossover Trials in Healthy Male Subjects. Tomkinson H; McBride E; Martin P; Lisbon E; Dymond AW; Cantarini M; So K; Holt D Clin Ther; 2017 Nov; 39(11):2260-2275.e1. PubMed ID: 28985960 [TBL] [Abstract][Full Text] [Related]
57. [Bioequivalence and bioavailability after single administration of effervescent ranitidine tablets]. Hartmann B; Schmieder G; Tetzloff W; Töberich H Arzneimittelforschung; 1992 Aug; 42(8):1020-2. PubMed ID: 1418073 [TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetics and relative bioavailability of nimodipine capsules and tablets in 8 Chinese healthy men. Guo LQ; Tan HS; Chen G Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):295-7. PubMed ID: 8249618 [TBL] [Abstract][Full Text] [Related]
59. Bioavailability of nifedipine from different oral dosage forms in healthy volunteers. Leucuţa SE; Vida-Simiti L; Căprioară MG; Făgărăşan E; Olinic N; Manasia M; Vlaicu R Pharmazie; 1989 May; 44(5):336-8. PubMed ID: 2772014 [TBL] [Abstract][Full Text] [Related]
60. Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects. Sun H; Ting L; Machineni S; Praestgaard J; Kuemmell A; Stein DS; Sunkara G; Kovacs SJ; Villano S; Tanaka SK Antimicrob Agents Chemother; 2016 Dec; 60(12):7431-7435. PubMed ID: 27736760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]